Search results for: Health Policy and Regulation
Filter search results
OHE Occasional Paper Critiques the Claxton et al. £13,000 per QALY Estimate
24 February 2015
…Trusts (PCTs) in England?” If we can estimate the health gain achieved from additional health spending we can better understand the potential health consequences of spending money on other things…
OHE is Recruiting for Two Positions: A Deputy Director and an Economist.
26 March 2015
…and energetic economist, for the role of deputy to the Director of the OHE. Managerial experience within a research and consultancy setting in the health and/or life sciences sector is…
OHE at ISPOR Philadelphia Part 2: Risk Sharing, Medical Breakthroughs, Early Access and Drug Development Costs
12 May 2015
…sharing and performance based arrangements (PBRSAs), including trends, and the challenges involved in putting them in place. Several examples of performance-based schemes from Europe, the United States, and Australia will…
OHE at HTAi Oslo: A New Drug Development Paradigm, and the Effect of NICE Decisions Abroad
19 June 2015
…Annual Meeting, Global Efforts in Knowledge Transfer: HTA to Health Policy and Practice, took place on 15-17 June 2015 in Oslo. Members of the OHE team attended and presented key…
OHE Appoints New Deputy Director: Associate Professor Paula Lorgelly
13 August 2015
…maternal mental health; HIV; and workplace health promotion. During her career Paula has developed expertise in: Econometric analyses of panel data and cross-sectional survey data, including analyses of large linked…
Victoria Jordan
3 February 2023
Victoria Jordan is Head of HTA and Market Access Policy at the Association of the British Pharmaceutical Industry (ABPI) which he joined in November 2017.
Mata Charokopou – 2022 Prize Finalist
18 January 2023
…Greece, in 2010, with a PharmD in Pharmacy and she received a Master of Science in Health Economics, Policy and Law from the Erasmus University of Rotterdam, Netherlands, in 2011….
Cornerstones of “Fair” Drug Coverage: Appropriate Cost – Sharing and Utilization Management Policies for Pharmaceuticals
1 September 2020
…the paper, the authors undertook a literature review and conducted stakeholder interviews. Representatives from patient organizations and clinical societies joined ICER’s Policy Leadership Forum – senior policy leaders from 25…